SIGMAFAST™ 3,3′-Diaminobenzidine tablets
SIGMA/D4293 - tablet, To prepare 5 mL
Synonym: DAB tablets
CAS Number: 91-95-2
MDL Number: MFCD00007725
Product Type: Chemical
| form | tablet |
| InChI | 1S/C12H14N4/c13-9-3-1-7(5 |
| InChI key | HSTOKWSFWGCZMH-UHFFFAOYSA |
| Quality Level | 200 ![]() |
| SMILES string | Nc1ccc(cc1N)-c2ccc(N)c(N) |
| storage temp. | −20°C |
| Application: | Developed for use in immunohistology and immunoblotting as a precipitating substrate for the localization of peroxidase activity. DAB is the immunohistology substrate of choice as it produces an intense brown-black stain which is resistant to alcohol. Slides stained with DAB may be dehydrated, mounted in resinous media, and stored for future reference. SIGMAFAST™ DAB Tablets require no additional buffers or steps to prepare an active substrate solution. Tablets are individually packaged in foil packets |
| Application: | SIGMAFAST™ 3,3′-Diaminobenzidine tablets has been used as a chromogen for visualization in immunohistochemistry of gonad tissue, thymus, dental chronic periapical lesions and gall bladder sections. |
| Legal Information: | SIGMAFAST is a trademark of Sigma-Aldrich Co. LLC |
| Other Notes: | 2024 CiteAb Award Winner for Supplier Succeeding in Parkinson′s Research ![]() |
| Preparation Note: | Each tablet set dissolved in 5 mL deionized water yields a ready-to-use buffered solution containing DAB and urea hydrogen peroxide. |
| Symbol | ![]() GHS07,GHS08 |
| Signal word | Danger |
| Hazard statements | H315 - H319 - H335 - H341 - H350 |
| Precautionary statements | P202 - P261 - P264 - P302 + P352 - P305 + P351 + P338 - P308 + P313 |
| Hazard Codes | T |
| Risk Statements | 45-36/37/38-68 |
| Safety Statements | 53-26-36/37-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 12352204 |



